Jenny Iversen1, Handan Wand1, Po-Lin Chan2, Linh-Vi Le2, Lisa Maher1. 1. Kirby Institute, Faculty of Medicine, UNSW Sydney, Sydney, NSW 2052, Australia. 2. World Health Organization Regional Office for the Western Pacific, Manila 1003, Philippines.
Abstract
BACKGROUND: This review aimed to identify hepatitis C virus (HCV) prevalence estimates among the general population and six key populations (people who inject drugs, men who have sex with men, sex workers, prisoners/detainees, Indigenous people, and migrants) in the World Health Organization Western Pacific Region (WHO WPR). METHODS: Original research articles published between 2016 and 2020 were identified from bibliographic databases. Publications were retrieved, replicas removed, and abstracts screened. Retained full texts were assessed and excluded if inclusion criteria were not met. Methodological quality was assessed using the Johanna Briggs Institute critical appraisal checklist for prevalence data. Data on HCV exposure and active infection were extracted and aggregated and forest plots generated for each population by country. RESULTS: There were no HCV prevalence estimates in any population for more than half of WPR countries and territories. Among the 76 estimates, 97% presented prevalence of exposure and 33% prevalence of active infection. General population viraemic prevalence was 1% or less, except in Mongolia. Results confirm the endemic nature of HCV among people who inject drugs, with estimates of exposure ranging from 30% in Cambodia to 76% in Hong Kong. CONCLUSIONS: Countries require detailed knowledge of HCV prevalence in diverse populations to evaluate the impact of efforts to support WHO HCV elimination goals. Results provide baseline estimates from which to monitor and evaluate progress and by which to benchmark future elimination efforts.
BACKGROUND: This review aimed to identify hepatitis C virus (HCV) prevalence estimates among the general population and six key populations (people who inject drugs, men who have sex with men, sex workers, prisoners/detainees, Indigenous people, and migrants) in the World Health Organization Western Pacific Region (WHO WPR). METHODS: Original research articles published between 2016 and 2020 were identified from bibliographic databases. Publications were retrieved, replicas removed, and abstracts screened. Retained full texts were assessed and excluded if inclusion criteria were not met. Methodological quality was assessed using the Johanna Briggs Institute critical appraisal checklist for prevalence data. Data on HCV exposure and active infection were extracted and aggregated and forest plots generated for each population by country. RESULTS: There were no HCV prevalence estimates in any population for more than half of WPR countries and territories. Among the 76 estimates, 97% presented prevalence of exposure and 33% prevalence of active infection. General population viraemic prevalence was 1% or less, except in Mongolia. Results confirm the endemic nature of HCV among people who inject drugs, with estimates of exposure ranging from 30% in Cambodia to 76% in Hong Kong. CONCLUSIONS: Countries require detailed knowledge of HCV prevalence in diverse populations to evaluate the impact of efforts to support WHO HCV elimination goals. Results provide baseline estimates from which to monitor and evaluate progress and by which to benchmark future elimination efforts.
Entities:
Keywords:
Western Pacific Region; elimination; hepatitis C virus; prevalence; systematic review; viral hepatitis
Authors: Jenny Iversen; Gregory J Dore; Mitchell Starr; Beth Catlett; Philip Cunningham; Louise Geddes; Lisa Maher Journal: Int J Drug Policy Date: 2020-07-06
Authors: Kristen Glenister; William Kemp; Dunya Tomic; David Simmons; Stuart Roberts Journal: Aust N Z J Public Health Date: 2020-11-30 Impact factor: 2.939
Authors: Marini Ramli; Zefarina Zulkafli; Geoffrey Keith Chambers; Raja Sabrina Amani Raja Zilan; Hisham Atan Edinur Journal: Oman Med J Date: 2020-10-20
Authors: G W Ding; S D Ye; F X Hei; Q L Lian; X D Pei; J Y Bai; D Zhou; Q Yang; S Hui; W Wang; A X Tu; L Pang Journal: Zhonghua Liu Xing Bing Xue Za Zhi Date: 2019-01-10
Authors: Xia An; Qunlu Sun; Fang Fang; Zhanhong Rao; Xiaowen Li; Yunhong Lv; Tong Li; Aihua Lin Journal: Int J Environ Res Public Health Date: 2019-12-23 Impact factor: 3.390
Authors: Louisa Degenhardt; Amy Peacock; Samantha Colledge; Janni Leung; Jason Grebely; Peter Vickerman; Jack Stone; Evan B Cunningham; Adam Trickey; Kostyantyn Dumchev; Michael Lynskey; Paul Griffiths; Richard P Mattick; Matthew Hickman; Sarah Larney Journal: Lancet Glob Health Date: 2017-10-23 Impact factor: 26.763